“…The efficiency of conventional methods of UC and CD treatment leaves much to be desired [1,[9][10][11]. Modern therapy of IBD includes biological therapy (antibodies to TNF-α, adhesion molecules, IL-12/23, IL-6R, endoscopic application of artificially grown pieces of tissues etc) and gene therapy (iRNA-technologies aimed at inhibition of the necessary genes) [2,3,7,12,13]. The application of nanoparticles for the transportation of drugs despite its high cost is also promising [2].…”